COVID-19 Vaccination Is Safe and Effective in Patients With Inflammatory Bowel Disease: Analysis of a Large Multi-institutional Research Network in the United States.
作者信息
Hadi Yousaf Bashir, Thakkar Shyam, Shah-Khan Sardar Momin, Hutson William, Sarwari Arif, Singh Shailendra
机构信息
Section of Gastroenterology and Hepatology, Department of Medicine, West Virginia University, Morgantown, West Virginia.
Department of Medicine, West Virginia University, Morgantown, West Virginia.
出版信息
Gastroenterology. 2021 Oct;161(4):1336-1339.e3. doi: 10.1053/j.gastro.2021.06.014. Epub 2021 Jun 15.
Abstract
摘要
相似文献
1
COVID-19 Vaccination Is Safe and Effective in Patients With Inflammatory Bowel Disease: Analysis of a Large Multi-institutional Research Network in the United States.
Gastroenterology. 2021 Oct;161(4):1336-1339.e3. doi: 10.1053/j.gastro.2021.06.014. Epub 2021 Jun 15.
2
Methotrexate for inflammatory bowel disease: time for reconsideration.
Expert Rev Gastroenterol Hepatol. 2019 May;13(5):407-409. doi: 10.1080/17474124.2019.1596797. Epub 2019 Mar 21.
3
Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease.
World J Gastroenterol. 2014 Aug 7;20(29):9675-90. doi: 10.3748/wjg.v20.i29.9675.
4
Expert opinion: experience with 6-mercaptopurine in the treatment of inflammatory bowel disease.
World J Gastroenterol. 2013 May 28;19(20):2979-84. doi: 10.3748/wjg.v19.i20.2979.
5
Preventing infective complications in inflammatory bowel disease.
World J Gastroenterol. 2014 Aug 7;20(29):9691-8. doi: 10.3748/wjg.v20.i29.9691.
6
Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
Gastroenterology. 2017 Jun;152(8):1901-1914.e3. doi: 10.1053/j.gastro.2017.02.004. Epub 2017 Feb 11.
7
Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
Gastroenterology. 2019 Jan;156(1):36-42. doi: 10.1053/j.gastro.2018.08.043. Epub 2018 Sep 7.
8
Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease.
Gastroenterology. 2021 Oct;161(4):1340-1343.e2. doi: 10.1053/j.gastro.2021.06.016. Epub 2021 Jun 15.
9
Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease.
Eur J Gastroenterol Hepatol. 2021 Mar 1;33(3):443-447. doi: 10.1097/MEG.0000000000002094.
10
Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs.
Atherosclerosis. 2014 Jun;234(2):346-51. doi: 10.1016/j.atherosclerosis.2014.03.023. Epub 2014 Mar 30.
引用本文的文献
1
Durability of Antibody Responses to SARS-CoV-2 Vaccination over 12 Months in Pediatric Inflammatory Bowel Disease.
Vaccines (Basel). 2025 May 22;13(6):549. doi: 10.3390/vaccines13060549.
2
Safety of COVID-19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases: A Cross-sectional Study in Egypt.
Oman Med J. 2024 Sep 30;39(5):e676. doi: 10.5001/omj.2024.107. eCollection 2024 Sep.
3
Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies.
Ann Med. 2025 Dec;57(1):2478319. doi: 10.1080/07853890.2025.2478319. Epub 2025 Mar 26.
4
Feasibility and Effectiveness of Vaccines for COVID-19: An Umbrella Review.
Arch Acad Emerg Med. 2024 Sep 10;13(1):e6. doi: 10.22037/aaem.v12i1.2357. eCollection 2025.
5
Vaccine Acceptance in Patients with Inflammatory Bowel Disease: Lessons Learned from the COVID-19 Pandemic.
Vaccines (Basel). 2024 May 18;12(5):551. doi: 10.3390/vaccines12050551.
6
Cytokine and chemokine profiles in ulcerative colitis relapse after coronavirus disease 2019 vaccination.
J Clin Biochem Nutr. 2024 Mar;74(2):127-135. doi: 10.3164/jcbn.23-26. Epub 2023 Sep 16.
7
A Practical Update on COVID-19 and Inflammatory Bowel Disease: COVID-19 Disease Risk and Vaccine Safety and Efficacy.
Gastroenterol Hepatol (N Y). 2024 Feb;20(2):88-97.
8
SARS-CoV-2 vaccination in inflammatory bowel disease patients is not associated with flares: a retrospective single-centre Swiss study.
Ann Med. 2024 Dec;56(1):2295979. doi: 10.1080/07853890.2023.2295979. Epub 2024 Jan 30.
9
BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign.
Viruses. 2023 Sep 21;15(9):1968. doi: 10.3390/v15091968.
10
Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study.
Inflamm Bowel Dis. 2024 Apr 3;30(4):602-616. doi: 10.1093/ibd/izad114.
Zotero 插件